BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Quintanal-Villalonga Á, Chan JM, Yu HA, Pe'er D, Sawyers CL, Sen T, Rudin CM. Lineage plasticity in cancer: a shared pathway of therapeutic resistance. Nat Rev Clin Oncol 2020;17:360-71. [PMID: 32152485 DOI: 10.1038/s41571-020-0340-z] [Cited by in Crossref: 58] [Cited by in F6Publishing: 94] [Article Influence: 29.0] [Reference Citation Analysis]
Number Citing Articles
1 Di Stefano B. Cell identity and plasticity uncoupled. Nat Cell Biol 2022. [PMID: 36075977 DOI: 10.1038/s41556-022-00943-7] [Reference Citation Analysis]
2 Niu Y, Förster S, Muders M. The Role of Perineural Invasion in Prostate Cancer and Its Prognostic Significance. Cancers 2022;14:4065. [DOI: 10.3390/cancers14174065] [Reference Citation Analysis]
3 Singh MK, Altameemi S, Lares M, Newton MA, Setaluri V. Role of dual specificity phosphatases (DUSPs) in melanoma cellular plasticity and drug resistance. Sci Rep 2022;12:14395. [PMID: 35999349 DOI: 10.1038/s41598-022-18578-x] [Reference Citation Analysis]
4 Takahashi K, Yasui H, Taki S, Shimizu M, Koike C, Taki K, Yukawa H, Baba Y, Kobayashi H, Sato K. Near‐infrared‐induced drug release from antibody–drug double conjugates exerts a cytotoxic photo‐bystander effect. Bioengineering & Transla Med. [DOI: 10.1002/btm2.10388] [Reference Citation Analysis]
5 Chan JM, Zaidi S, Love JR, Zhao JL, Setty M, Wadosky KM, Gopalan A, Choo ZN, Persad S, Choi J, LaClair J, Lawrence KE, Chaudhary O, Xu T, Masilionis I, Linkov I, Wang S, Lee C, Barlas A, Morris MJ, Mazutis L, Chaligne R, Chen Y, Goodrich DW, Karthaus WR, Pe'er D, Sawyers CL. Lineage plasticity in prostate cancer depends on JAK/STAT inflammatory signaling. Science 2022;:eabn0478. [PMID: 35981096 DOI: 10.1126/science.abn0478] [Reference Citation Analysis]
6 Zhu C, Guan X, Zhang X, Luan X, Song Z, Cheng X, Zhang W, Qin JJ. Targeting KRAS mutant cancers: from druggable therapy to drug resistance. Mol Cancer 2022;21:159. [PMID: 35922812 DOI: 10.1186/s12943-022-01629-2] [Reference Citation Analysis]
7 Yamashita N, Kufe D. Addiction of Cancer Stem Cells to MUC1-C in Triple-Negative Breast Cancer Progression. Int J Mol Sci 2022;23:8219. [PMID: 35897789 DOI: 10.3390/ijms23158219] [Reference Citation Analysis]
8 Zhou H, He Q, Li C, Alsharafi BLM, Deng L, Long Z, Gan Y. Focus on the tumor microenvironment: A seedbed for neuroendocrine prostate cancer. Front Cell Dev Biol 2022;10:955669. [DOI: 10.3389/fcell.2022.955669] [Reference Citation Analysis]
9 Islam R, Mishra J, Polavaram NS, Bhattacharya S, Hong Z, Bodas S, Sharma S, Bouska A, Gilbreath T, Said AM, Smith LM, Teply BA, Muders MH, Batra SK, Datta K, Dutta S. Neuropilin-2 axis in regulating secretory phenotype of neuroendocrine-like prostate cancer cells and its implication in therapy resistance. Cell Rep 2022;40:111097. [PMID: 35858551 DOI: 10.1016/j.celrep.2022.111097] [Reference Citation Analysis]
10 Storck WK, May AM, Westbrook TC, Duan Z, Morrissey C, Yates JA, Alumkal JJ. The Role of Epigenetic Change in Therapy-Induced Neuroendocrine Prostate Cancer Lineage Plasticity. Front Endocrinol 2022;13:926585. [DOI: 10.3389/fendo.2022.926585] [Reference Citation Analysis]
11 Tang Y, Zhang Z, Chen Y, Qin S, Zhou L, Gao W, Shen Z. Metabolic Adaptation-Mediated Cancer Survival and Progression in Oxidative Stress. Antioxidants 2022;11:1324. [DOI: 10.3390/antiox11071324] [Reference Citation Analysis]
12 Orstad G, Fort G, Parnell TJ, Jones A, Stubben C, Lohman B, Gillis KL, Orellana W, Tariq R, Klingbeil O, Kaestner K, Vakoc CR, Spike BT, Snyder EL. FoxA1 and FoxA2 control growth and cellular identity in NKX2-1-positive lung adenocarcinoma. Dev Cell 2022:S1534-5807(22)00458-0. [PMID: 35835117 DOI: 10.1016/j.devcel.2022.06.017] [Reference Citation Analysis]
13 Shin DS, Park K, Garon E, Dubinett S. Targeting EZH2 to overcome the resistance to immunotherapy in lung cancer. Seminars in Oncology 2022. [DOI: 10.1053/j.seminoncol.2022.06.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Mirzaei S, Paskeh MDA, Okina E, Gholami MH, Hushmandi K, Hashemi M, Kalu A, Zarrabi A, Nabavi N, Rabiee N, Sharifi E, Karimi-Maleh H, Ashrafizadeh M, Kumar AP, Wang Y. Molecular Landscape of LncRNAs in Prostate Cancer: A focus on pathways and therapeutic targets for intervention. J Exp Clin Cancer Res 2022;41:214. [PMID: 35773731 DOI: 10.1186/s13046-022-02406-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
15 Stella GM, Scialò F, Bortolotto C, Agustoni F, Sanci V, Saddi J, Casali L, Corsico AG, Bianco A. Pragmatic Expectancy on Microbiota and Non-Small Cell Lung Cancer: A Narrative Review. Cancers 2022;14:3131. [DOI: 10.3390/cancers14133131] [Reference Citation Analysis]
16 Fan T, Kuang G, Long R, Han Y, Wang J. The overall process of metastasis: From initiation to a new tumor. Biochim Biophys Acta Rev Cancer 2022;1877:188750. [PMID: 35728735 DOI: 10.1016/j.bbcan.2022.188750] [Reference Citation Analysis]
17 Cao S, Wang JR, Ji S, Yang P, Dai Y, Guo S, Montierth MD, Shen JP, Zhao X, Chen J, Lee JJ, Guerrero PA, Spetsieris N, Engedal N, Taavitsainen S, Yu K, Livingstone J, Bhandari V, Hubert SM, Daw NC, Futreal PA, Efstathiou E, Lim B, Viale A, Zhang J, Nykter M, Czerniak BA, Brown PH, Swanton C, Msaouel P, Maitra A, Kopetz S, Campbell P, Speed TP, Boutros PC, Zhu H, Urbanucci A, Demeulemeester J, Van Loo P, Wang W. Estimation of tumor cell total mRNA expression in 15 cancer types predicts disease progression. Nat Biotechnol 2022. [PMID: 35697807 DOI: 10.1038/s41587-022-01342-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
18 Li ZF, Lu HZ, Chen YT, Bai XF, Wang TB, Fei H, Zhao DB. Mixed large and small cell neuroendocrine carcinoma of the stomach: A case report and review of literature. World J Clin Cases 2022; 10(16): 5502-5509 [DOI: 10.12998/wjcc.v10.i16.5502] [Reference Citation Analysis]
19 Nie W, Chen J, Wang B, Gao X. Nonviral vector system for cancer immunogene therapy. MedComm – Biomaterials and Applications 2022;1:mba2.10. [DOI: 10.1002/mba2.10] [Reference Citation Analysis]
20 Tang F, Xu D, Wang S, Wong CK, Martinez-Fundichely A, Lee CJ, Cohen S, Park J, Hill CE, Eng K, Bareja R, Han T, Liu EM, Palladino A, Di W, Gao D, Abida W, Beg S, Puca L, Meneses M, de Stanchina E, Berger MF, Gopalan A, Dow LE, Mosquera JM, Beltran H, Sternberg CN, Chi P, Scher HI, Sboner A, Chen Y, Khurana E. Chromatin profiles classify castration-resistant prostate cancers suggesting therapeutic targets. Science 2022;376:eabe1505. [PMID: 35617398 DOI: 10.1126/science.abe1505] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
21 Yang D, Jones MG, Naranjo S, Rideout WM 3rd, Min KHJ, Ho R, Wu W, Replogle JM, Page JL, Quinn JJ, Horns F, Qiu X, Chen MZ, Freed-Pastor WA, McGinnis CS, Patterson DM, Gartner ZJ, Chow ED, Bivona TG, Chan MM, Yosef N, Jacks T, Weissman JS. Lineage tracing reveals the phylodynamics, plasticity, and paths of tumor evolution. Cell 2022;185:1905-1923.e25. [PMID: 35523183 DOI: 10.1016/j.cell.2022.04.015] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
22 Petrazzuolo A, Maiuri MC, Zitvogel L, Kroemer G, Kepp O. Trial Watch: combination of tyrosine kinase inhibitors (TKIs) and immunotherapy. OncoImmunology 2022;11:2077898. [DOI: 10.1080/2162402x.2022.2077898] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
23 Liu J, Zhao Z, Wei S, Li B, Zhao Z. Genomic features of Chinese small cell lung cancer. BMC Med Genomics 2022;15:117. [PMID: 35596192 DOI: 10.1186/s12920-022-01255-3] [Reference Citation Analysis]
24 Kufe DW. Chronic activation of MUC1-C in wound repair promotes progression to cancer stem cells. J Cancer Metastasis Treat 2022;8:12. [PMID: 35539431 DOI: 10.20517/2394-4722.2022.03] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 Pinto F, Dibitetto F, Ragonese M, Bassi P. Mechanisms of Resistance to Second-Generation Antiandrogen Therapy for Prostate Cancer: Actual Knowledge and Perspectives. Medical Sciences 2022;10:25. [DOI: 10.3390/medsci10020025] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
26 Gurova K. Can aggressive cancers be identified by the "aggressiveness" of their chromatin? Bioessays 2022;:e2100212. [PMID: 35452144 DOI: 10.1002/bies.202100212] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
27 Lissa D, Takahashi N, Desai P, Manukyan I, Schultz CW, Rajapakse V, Velez MJ, Mulford D, Roper N, Nichols S, Vilimas R, Sciuto L, Chen Y, Guha U, Rajan A, Atkinson D, El Meskini R, Weaver Ohler Z, Thomas A. Heterogeneity of neuroendocrine transcriptional states in metastatic small cell lung cancers and patient-derived models. Nat Commun 2022;13:2023. [PMID: 35440132 DOI: 10.1038/s41467-022-29517-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
28 Caeser R, Egger JV, Chavan S, Socci ND, Jones CB, Kombak FE, Asher M, Roehrl MH, Shah NS, Allaj V, Manoj P, Tischfield SE, Kulick A, Meneses M, Iacobuzio-Donahue CA, Lai WV, Bhanot U, Baine MK, Rekhtman N, Hollmann TJ, de Stanchina E, Poirier JT, Rudin CM, Sen T. Genomic and transcriptomic analysis of a library of small cell lung cancer patient-derived xenografts. Nat Commun 2022;13:2144. [PMID: 35440124 DOI: 10.1038/s41467-022-29794-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
29 Pan X, Wang J, Guo L, Na F, Du J, Chen X, Zhong A, Zhao L, Zhang L, Zhang M, Wan X, Wang M, Liu H, Dai S, Tan P, Chen J, Liu Y, Hu B, Chen C. Identifying a confused cell identity for esophageal squamous cell carcinoma. Signal Transduct Target Ther 2022;7:122. [PMID: 35418165 DOI: 10.1038/s41392-022-00946-8] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
30 Ríos-Hoyo A, Moliner L, Arriola E. Acquired Mechanisms of Resistance to Osimertinib-The Next Challenge. Cancers (Basel) 2022;14:1931. [PMID: 35454838 DOI: 10.3390/cancers14081931] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
31 Han H, Wang Y, Curto J, Gurrapu S, Laudato S, Rumandla A, Chakraborty G, Wang X, Chen H, Jiang Y, Kumar D, Caggiano EG, Capogiri M, Zhang B, Ji Y, Maity SN, Hu M, Bai S, Aparicio AM, Efstathiou E, Logothetis CJ, Navin N, Navone NM, Chen Y, Giancotti FG. Mesenchymal and stem-like prostate cancer linked to therapy-induced lineage plasticity and metastasis. Cell Rep 2022;39:110595. [PMID: 35385726 DOI: 10.1016/j.celrep.2022.110595] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
32 Moscat J, Linares JF, Duran A, Diaz-meco MT. Protein kinase Cλ/ι in cancer: a contextual balance of time and signals. Trends in Cell Biology 2022. [DOI: 10.1016/j.tcb.2022.04.002] [Reference Citation Analysis]
33 Flores M, Goodrich DW. Retinoblastoma Protein Paralogs and Tumor Suppression. Front Genet 2022;13:818719. [DOI: 10.3389/fgene.2022.818719] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
34 Tan W, Zheng T, Wang A, Roacho J, Thao S, Du P, Jia S, Yu J, King BL, Kohli M. Dynamic changes in gene alterations during chemotherapy in metastatic castrate resistant prostate cancer. Sci Rep 2022;12:4672. [PMID: 35304525 DOI: 10.1038/s41598-022-08520-6] [Reference Citation Analysis]
35 Yin X, Li Y, Wang H, Jia T, Wang E, Luo Y, Wei Y, Qin Z, Ma X. Small cell lung cancer transformation: From pathogenesis to treatment. Semin Cancer Biol 2022:S1044-579X(22)00062-1. [PMID: 35276343 DOI: 10.1016/j.semcancer.2022.03.006] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
36 Han L. Brain metastases: Nanomedicine-boosted diagnosis and treatment. Medicine in Drug Discovery 2022;13:100111. [DOI: 10.1016/j.medidd.2021.100111] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
37 Joshi BP, Bhandare VV, Patel P, Sharma A, Patel R, Krishnamurthy R. Molecular modelling studies and identification of novel phytochemical inhibitor of DLL3. J Biomol Struct Dyn 2022;:1-21. [PMID: 35220906 DOI: 10.1080/07391102.2022.2045224] [Reference Citation Analysis]
38 Pan Z, Liu H, Chen J. [Lung Cancer Stem-like Cells and Drug Resistance]. Zhongguo Fei Ai Za Zhi 2022;25:111-7. [PMID: 35224964 DOI: 10.3779/j.issn.1009-3419.2022.102.02] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
39 Hagiwara M, Fushimi A, Bhattacharya A, Yamashita N, Morimoto Y, Oya M, Withers HG, Hu Q, Liu T, Liu S, Wong KK, Long MD, Kufe D. MUC1-C integrates type II interferon and chromatin remodeling pathways in immunosuppression of prostate cancer. OncoImmunology 2022;11:2029298. [DOI: 10.1080/2162402x.2022.2029298] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
40 Santos NJ, Ximenes PP, Constantino FB, Carvalho HF, Felisbino SL. Mucinous metaplasia in Pten conditional knockout mice and mucin family genes as prognostic markers for prostate cancer. Life Sci 2022;293:120264. [PMID: 35031262 DOI: 10.1016/j.lfs.2021.120264] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
41 Shui X, Xu R, Zhang C, Meng H, Zhao J, Shi C. Advances in neuroendocrine prostate cancer research: From model construction to molecular network analyses. Lab Invest 2021. [PMID: 34937865 DOI: 10.1038/s41374-021-00716-0] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
42 Malinova A, Veghini L, Real FX, Corbo V. Cell Lineage Infidelity in PDAC Progression and Therapy Resistance. Front Cell Dev Biol 2021;9:795251. [PMID: 34926472 DOI: 10.3389/fcell.2021.795251] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
43 Jiang Y, Zhao H, Chen Y, Li K, Li T, Chen J, Zhang B, Guo C, Qing L, Shen J, Liu X, Gu P. Exosomal long noncoding RNA HOXD-AS1 promotes prostate cancer metastasis via miR-361-5p/FOXM1 axis. Cell Death Dis 2021;12:1129. [PMID: 34864822 DOI: 10.1038/s41419-021-04421-0] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
44 Tang YJ, Puviindran V, Xiang Y, Yahara Y, Zhang H, Nadesan P, Diao Y, Kirsch DG, Alman BA. Tumor-propagating side population cells are a dynamic subpopulation in undifferentiated pleomorphic sarcoma. JCI Insight 2021;6:e148768. [PMID: 34618689 DOI: 10.1172/jci.insight.148768] [Reference Citation Analysis]
45 Huang Z, Liu Z, Cheng X, Han Z, Li J, Xia T, Gao Y, Wei L. Prognostic significance of HSF2BP in lung adenocarcinoma. Ann Transl Med 2021;9:1559. [PMID: 34790765 DOI: 10.21037/atm-21-4935] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
46 Cao Y. Neural is Fundamental: Neural Stemness as the Ground State of Cell Tumorigenicity and Differentiation Potential. Stem Cell Rev Rep 2021. [PMID: 34714532 DOI: 10.1007/s12015-021-10275-y] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
47 Rekhtman N. Lung neuroendocrine neoplasms: recent progress and persistent challenges. Mod Pathol 2021. [PMID: 34663914 DOI: 10.1038/s41379-021-00943-2] [Cited by in F6Publishing: 12] [Reference Citation Analysis]
48 Luan Z, Morimoto Y, Fushimi A, Yamashita N, Suo W, Bhattacharya A, Hagiwara M, Jin C, Kufe D. MUC1-C Dictates Neuroendocrine Lineage Specification in Pancreatic Ductal Adenocarcinomas. Carcinogenesis 2021:bgab097. [PMID: 34657147 DOI: 10.1093/carcin/bgab097] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
49 Quintanal-Villalonga A, Taniguchi H, Zhan YA, Hasan MM, Chavan SS, Meng F, Uddin F, Allaj V, Manoj P, Shah NS, Chan JM, Ciampricotti M, Chow A, Offin M, Ray-Kirton J, Egger JD, Bhanot UK, Linkov I, Asher M, Roehrl MH, Ventura K, Qiu J, de Stanchina E, Chang JC, Rekhtman N, Houck-Loomis B, Koche RP, Yu HA, Sen T, Rudin CM. Comprehensive molecular characterization of lung tumors implicates AKT and MYC signaling in adenocarcinoma to squamous cell transdifferentiation. J Hematol Oncol 2021;14:170. [PMID: 34656143 DOI: 10.1186/s13045-021-01186-z] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
50 Pastorino L, Grillo F, Albertelli M, Ghiorzo P, Bruno W. Insights into Mechanisms of Tumorigenesis in Neuroendocrine Neoplasms. Int J Mol Sci 2021;22:10328. [PMID: 34638668 DOI: 10.3390/ijms221910328] [Reference Citation Analysis]
51 Xin L. EZH2 accompanies prostate cancer progression. Nat Cell Biol 2021;23:934-6. [PMID: 34489575 DOI: 10.1038/s41556-021-00744-4] [Reference Citation Analysis]
52 Chai X, Zhang X, Li W, Chai J. Small cell lung cancer transformation during antitumor therapies: A systematic review. Open Med (Wars) 2021;16:1160-7. [PMID: 34435141 DOI: 10.1515/med-2021-0321] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
53 von Itzstein MS, Drapkin BJ, Minna JD. How lung cancer cells change identity. Elife 2021;10:e71610. [PMID: 34346867 DOI: 10.7554/eLife.71610] [Reference Citation Analysis]
54 Rosigkeit S, Kruchem M, Thies D, Kreft A, Eichler E, Boegel S, Jansky S, Siegl D, Kaps L, Pickert G, Haehnel P, Kindler T, Hartwig UF, Guerra C, Barbacid M, Schuppan D, Bockamp E. Definitive evidence for Club cells as progenitors for mutant Kras/Trp53-deficient lung cancer. Int J Cancer 2021. [PMID: 34331774 DOI: 10.1002/ijc.33756] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
55 Tanaka K, Yu HA, Yang S, Han S, Selcuklu SD, Kim K, Ramani S, Ganesan YT, Moyer A, Sinha S, Xie Y, Ishizawa K, Osmanbeyoglu HU, Lyu Y, Roper N, Guha U, Rudin CM, Kris MG, Hsieh JJ, Cheng EH. Targeting Aurora B kinase prevents and overcomes resistance to EGFR inhibitors in lung cancer by enhancing BIM- and PUMA-mediated apoptosis. Cancer Cell 2021:S1535-6108(21)00383-4. [PMID: 34388376 DOI: 10.1016/j.ccell.2021.07.006] [Cited by in F6Publishing: 10] [Reference Citation Analysis]
56 Thankamony AP, Subbalakshmi AR, Jolly MK, Nair R. Lineage Plasticity in Cancer: The Tale of a Skin-Walker. Cancers (Basel) 2021;13:3602. [PMID: 34298815 DOI: 10.3390/cancers13143602] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
57 Lin SR, Yeh HL, Liu YN. Interplay of Epidermal Growth Factor Receptor and Signal Transducer and Activator of Transcription 3 in Prostate Cancer: Beyond Androgen Receptor Transactivation. Cancers (Basel) 2021;13:3452. [PMID: 34298665 DOI: 10.3390/cancers13143452] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
58 Wang P, Zhang H, Chen P, Sun Z, Zhang Z, Yin Q, Sun H, Yu J. The Presence of Genomic Instability in Cerebrospinal Fluid in Patients with Meningeal Metastasis. Cancer Manag Res 2021;13:4853-63. [PMID: 34188538 DOI: 10.2147/CMAR.S295368] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
59 Schiewer MJ, Knudsen KE. Basic Science and Molecular Genetics of Prostate Cancer Aggressiveness. Urol Clin North Am 2021;48:339-47. [PMID: 34210489 DOI: 10.1016/j.ucl.2021.04.004] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
60 Norton JP, Augert A, Eastwood E, Basom R, Rudin CM, MacPherson D. Protein neddylation as a therapeutic target in pulmonary and extrapulmonary small cell carcinomas. Genes Dev 2021;35:870-87. [PMID: 34016692 DOI: 10.1101/gad.348316.121] [Reference Citation Analysis]
61 Dong Z, Yan S, Liu B, Hao Y, Lin L, Chang T, Sun H, Wang Y, Li H, Wu H, Hang X, He S, Hu J, Xue X, Wu N, Chang L. Single Living Cell Analysis Nanoplatform for High-Throughput Interrogation of Gene Mutation and Cellular Behavior. Nano Lett 2021;21:4878-86. [PMID: 33830766 DOI: 10.1021/acs.nanolett.1c00199] [Cited by in Crossref: 2] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
62 Thomas A, Takahashi N, Rajapakse VN, Zhang X, Sun Y, Ceribelli M, Wilson KM, Zhang Y, Beck E, Sciuto L, Nichols S, Elenbaas B, Puc J, Dahmen H, Zimmermann A, Varonin J, Schultz CW, Kim S, Shimellis H, Desai P, Klumpp-Thomas C, Chen L, Travers J, McKnight C, Michael S, Itkin Z, Lee S, Yuno A, Lee MJ, Redon CE, Kindrick JD, Peer CJ, Wei JS, Aladjem MI, Figg WD, Steinberg SM, Trepel JB, Zenke FT, Pommier Y, Khan J, Thomas CJ. Therapeutic targeting of ATR yields durable regressions in small cell lung cancers with high replication stress. Cancer Cell 2021;39:566-579.e7. [PMID: 33848478 DOI: 10.1016/j.ccell.2021.02.014] [Cited by in Crossref: 6] [Cited by in F6Publishing: 25] [Article Influence: 6.0] [Reference Citation Analysis]
63 da Silva EM, Fix DJ, Sebastiao APM, Selenica P, Ferrando L, Kim SH, Stylianou A, Da Cruz Paula A, Pareja F, Smith ES, Zehir A, Konner JA, Cadoo K, Reis-Filho JS, Abu-Rustum NR, Mueller JJ, Weigelt B, Park KJ. Mesonephric and mesonephric-like carcinomas of the female genital tract: molecular characterization including cases with mixed histology and matched metastases. Mod Pathol 2021;34:1570-87. [PMID: 33772212 DOI: 10.1038/s41379-021-00799-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
64 Schoenfeld AJ, O'Cearbhaill RE. How Do We Meet the Challenge of Chimeric Antigen Receptor T-Cell Therapy for Solid Tumors? Cancer J 2021;27:134-42. [PMID: 33750073 DOI: 10.1097/PPO.0000000000000516] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
65 Shlyakhtina Y, Moran KL, Portal MM. Genetic and Non-Genetic Mechanisms Underlying Cancer Evolution. Cancers (Basel) 2021;13:1380. [PMID: 33803675 DOI: 10.3390/cancers13061380] [Cited by in Crossref: 3] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
66 Vlachavas EI, Bohn J, Ückert F, Nürnberg S. A Detailed Catalogue of Multi-Omics Methodologies for Identification of Putative Biomarkers and Causal Molecular Networks in Translational Cancer Research. Int J Mol Sci 2021;22:2822. [PMID: 33802234 DOI: 10.3390/ijms22062822] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
67 Khaliq M, Manikkam M, Martinez ED, Fallahi-Sichani M. Epigenetic modulation reveals differentiation state specificity of oncogene addiction. Nat Commun 2021;12:1536. [PMID: 33750776 DOI: 10.1038/s41467-021-21784-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
68 Wei W, Li QG, Long X, Hu GH, He HJ, Huang YB, Yi XL. Sarcomatoid carcinoma of the prostate with bladder invasion shortly after androgen deprivation: Two case reports. World J Clin Cases 2021; 9(7): 1668-1675 [PMID: 33728311 DOI: 10.12998/wjcc.v9.i7.1668] [Reference Citation Analysis]
69 Drapkin BJ, Minna JD. Studying Lineage Plasticity One Cell at a Time. Cancer Cell 2020;38:150-2. [PMID: 32781039 DOI: 10.1016/j.ccell.2020.07.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
70 Liu Y, Guo W. SOX factors as cell-state regulators in the mammary gland and breast cancer. Semin Cell Dev Biol 2021;114:126-33. [PMID: 33583737 DOI: 10.1016/j.semcdb.2021.01.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
71 Manic G, Musella M, Corradi F, Sistigu A, Vitale S, Soliman Abdel Rehim S, Mattiello L, Malacaria E, Galassi C, Signore M, Pallocca M, Scalera S, Goeman F, De Nicola F, Guarracino A, Pennisi R, Antonangeli F, Sperati F, Baiocchi M, Biffoni M, Fanciulli M, Maugeri-Saccà M, Franchitto A, Pichierri P, De Maria R, Vitale I. Control of replication stress and mitosis in colorectal cancer stem cells through the interplay of PARP1, MRE11 and RAD51. Cell Death Differ 2021;28:2060-82. [PMID: 33531658 DOI: 10.1038/s41418-020-00733-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
72 Yang L, Kim TH, Cho HY, Luo J, Lee JM, Chueng SD, Hou Y, Yin PT, Han J, Kim JH, Chung BG, Choi JW, Lee KB. Hybrid Graphene-Gold Nanoparticle-based Nucleic Acid Conjugates for Cancer-Specific Multimodal Imaging and Combined Therapeutics. Adv Funct Mater 2021;31:2006918. [PMID: 33776614 DOI: 10.1002/adfm.202006918] [Cited by in Crossref: 17] [Cited by in F6Publishing: 22] [Article Influence: 17.0] [Reference Citation Analysis]
73 Baram T, Rubinstein-Achiasaf L, Ben-Yaakov H, Ben-Baruch A. Inflammation-Driven Breast Tumor Cell Plasticity: Stemness/EMT, Therapy Resistance and Dormancy. Front Oncol 2020;10:614468. [PMID: 33585241 DOI: 10.3389/fonc.2020.614468] [Cited by in Crossref: 4] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
74 Ritchie S, Reed DA, Pereira BA, Timpson P. The cancer cell secretome drives cooperative manipulation of the tumour microenvironment to accelerate tumourigenesis. Fac Rev 2021;10:4. [PMID: 33659922 DOI: 10.12703/r/10-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
75 Reva BA, Omelchenko T, Nair SS, Tewari AK. Immune Escape in Prostate Cancer: Known and Predicted Mechanisms and Targets. Urol Clin North Am 2020;47:e9-e16. [PMID: 33446324 DOI: 10.1016/j.ucl.2020.10.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
76 Rudin CM, Brambilla E, Faivre-Finn C, Sage J. Small-cell lung cancer. Nat Rev Dis Primers 2021;7:3. [PMID: 33446664 DOI: 10.1038/s41572-020-00235-0] [Cited by in Crossref: 13] [Cited by in F6Publishing: 101] [Article Influence: 13.0] [Reference Citation Analysis]
77 Haffner MC, Zwart W, Roudier MP, True LD, Nelson WG, Epstein JI, De Marzo AM, Nelson PS, Yegnasubramanian S. Genomic and phenotypic heterogeneity in prostate cancer. Nat Rev Urol 2021;18:79-92. [PMID: 33328650 DOI: 10.1038/s41585-020-00400-w] [Cited by in Crossref: 6] [Cited by in F6Publishing: 73] [Article Influence: 3.0] [Reference Citation Analysis]
78 Wang Y, Chen J, Wu Z, Ding W, Gao S, Gao Y, Xu C. Mechanisms of enzalutamide resistance in castration-resistant prostate cancer and therapeutic strategies to overcome it. Br J Pharmacol 2021;178:239-61. [PMID: 33150960 DOI: 10.1111/bph.15300] [Cited by in Crossref: 1] [Cited by in F6Publishing: 16] [Article Influence: 0.5] [Reference Citation Analysis]
79 Rubin MA, Bristow RG, Thienger PD, Dive C, Imielinski M. Impact of Lineage Plasticity to and from a Neuroendocrine Phenotype on Progression and Response in Prostate and Lung Cancers. Mol Cell 2020;80:562-77. [PMID: 33217316 DOI: 10.1016/j.molcel.2020.10.033] [Cited by in Crossref: 5] [Cited by in F6Publishing: 19] [Article Influence: 2.5] [Reference Citation Analysis]
80 Peitzsch C, Gorodetska I, Klusa D, Shi Q, Alves TC, Pantel K, Dubrovska A. Metabolic regulation of prostate cancer heterogeneity and plasticity. Semin Cancer Biol 2020:S1044-579X(20)30261-3. [PMID: 33290846 DOI: 10.1016/j.semcancer.2020.12.002] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
81 Swayden M, Chhouri H, Anouar Y, Grumolato L. Tolerant/Persister Cancer Cells and the Path to Resistance to Targeted Therapy. Cells 2020;9:E2601. [PMID: 33291749 DOI: 10.3390/cells9122601] [Cited by in Crossref: 5] [Cited by in F6Publishing: 13] [Article Influence: 2.5] [Reference Citation Analysis]
82 Liu T, Han C, Fang P, Zhu H, Wang S, Ma Z, Zhang Q, Xia W, Wang J, Xu L, Yin R. Long non-coding RNAs in lung cancer: implications for lineage plasticity-mediated TKI resistance. Cell Mol Life Sci 2021;78:1983-2000. [PMID: 33170304 DOI: 10.1007/s00018-020-03691-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
83 Sarnella A, D'Avino G, Hill BS, Alterio V, Winum JY, Supuran CT, De Simone G, Zannetti A. A Novel Inhibitor of Carbonic Anhydrases Prevents Hypoxia-Induced TNBC Cell Plasticity. Int J Mol Sci 2020;21:E8405. [PMID: 33182416 DOI: 10.3390/ijms21218405] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
84 Kwon OJ, Zhang L, Jia D, Xin L. Sox2 is necessary for androgen ablation-induced neuroendocrine differentiation from Pten null Sca-1+ prostate luminal cells. Oncogene 2021;40:203-14. [PMID: 33110232 DOI: 10.1038/s41388-020-01526-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
85 Speidel JT, Affandi T, Jones DNM, Ferrara SE, Reyland ME. Functional proteomic analysis reveals roles for PKCδ in regulation of cell survival and cell death: Implications for cancer pathogenesis and therapy. Adv Biol Regul 2020;78:100757. [PMID: 33045516 DOI: 10.1016/j.jbior.2020.100757] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
86 Marine J, Dawson S, Dawson MA. Non-genetic mechanisms of therapeutic resistance in cancer. Nat Rev Cancer 2020;20:743-56. [DOI: 10.1038/s41568-020-00302-4] [Cited by in Crossref: 46] [Cited by in F6Publishing: 110] [Article Influence: 23.0] [Reference Citation Analysis]
87 Qin S, Jiang J, Lu Y, Nice EC, Huang C, Zhang J, He W. Emerging role of tumor cell plasticity in modifying therapeutic response. Signal Transduct Target Ther 2020;5:228. [PMID: 33028808 DOI: 10.1038/s41392-020-00313-5] [Cited by in Crossref: 15] [Cited by in F6Publishing: 40] [Article Influence: 7.5] [Reference Citation Analysis]
88 Kang N, Eccleston M, Clermont PL, Latarani M, Male DK, Wang Y, Crea F. EZH2 inhibition: a promising strategy to prevent cancer immune editing. Epigenomics 2020;12:1457-76. [PMID: 32938196 DOI: 10.2217/epi-2020-0186] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
89 Mizuno K, Tanigawa K, Nohata N, Misono S, Okada R, Asai S, Moriya S, Suetsugu T, Inoue H, Seki N. FAM64A: A Novel Oncogenic Target of Lung Adenocarcinoma Regulated by Both Strands of miR-99a (miR-99a-5p and miR-99a-3p). Cells 2020;9:E2083. [PMID: 32932948 DOI: 10.3390/cells9092083] [Cited by in Crossref: 2] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
90 Liu Y, White KA, Barber DL. Intracellular pH Regulates Cancer and Stem Cell Behaviors: A Protein Dynamics Perspective. Front Oncol 2020;10:1401. [PMID: 32983969 DOI: 10.3389/fonc.2020.01401] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
91 Marjanovic ND, Hofree M, Chan JE, Canner D, Wu K, Trakala M, Hartmann GG, Smith OC, Kim JY, Evans KV, Hudson A, Ashenberg O, Porter CBM, Bejnood A, Subramanian A, Pitter K, Yan Y, Delorey T, Phillips DR, Shah N, Chaudhary O, Tsankov A, Hollmann T, Rekhtman N, Massion PP, Poirier JT, Mazutis L, Li R, Lee JH, Amon A, Rudin CM, Jacks T, Regev A, Tammela T. Emergence of a High-Plasticity Cell State during Lung Cancer Evolution. Cancer Cell 2020;38:229-246.e13. [PMID: 32707077 DOI: 10.1016/j.ccell.2020.06.012] [Cited by in Crossref: 44] [Cited by in F6Publishing: 76] [Article Influence: 22.0] [Reference Citation Analysis]
92 Sánchez BG, Bort A, Vara-Ciruelos D, Díaz-Laviada I. Androgen Deprivation Induces Reprogramming of Prostate Cancer Cells to Stem-Like Cells. Cells 2020;9:E1441. [PMID: 32531951 DOI: 10.3390/cells9061441] [Cited by in Crossref: 7] [Cited by in F6Publishing: 14] [Article Influence: 3.5] [Reference Citation Analysis]
93 Ci X, Hao J, Dong X, Xue H, Wu R, Choi SYC, Haegert AM, Collins CC, Liu X, Lin D, Wang Y. Conditionally Reprogrammed Cells from Patient-Derived Xenograft to Model Neuroendocrine Prostate Cancer Development. Cells 2020;9:E1398. [PMID: 32512818 DOI: 10.3390/cells9061398] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
94 Ciesielski O, Biesiekierska M, Panthu B, Vialichka V, Pirola L, Balcerczyk A. The Epigenetic Profile of Tumor Endothelial Cells. Effects of Combined Therapy with Antiangiogenic and Epigenetic Drugs on Cancer Progression. Int J Mol Sci 2020;21:E2606. [PMID: 32283668 DOI: 10.3390/ijms21072606] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]